Global Diabetic Retinopathy Pipeline Report 2016 - Review of 41 Therapeutics Companies & Drug Profile Activity - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Diabetic Retinopathy - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Diabetic Retinopathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with the latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Retinopathy and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter-strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MoAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Diabetic Retinopathy Overview
  3. Therapeutics Development
  4. Pipeline Products for Diabetic Retinopathy - Overview
  5. Pipeline Products for Diabetic Retinopathy - Comparative Analysis
  6. Diabetic Retinopathy - Therapeutics under Development by Companies
  7. Diabetic Retinopathy - Therapeutics under Investigation by Universities/Institutes
  8. Diabetic Retinopathy Products Glance
  9. Late-Stage Products
  10. Clinical-Stage Products
  11. Early-Stage Products
  12. Diabetic Retinopathy - Products under Development by Companies
  13. Diabetic Retinopathy - Products under Investigation by Universities/Institutes
  14. Diabetic Retinopathy - Companies Involved in Therapeutics Development
  • Acucela Inc.
  • Aerie Pharmaceuticals, Inc.
  • Aerpio Therapeutics, Inc.
  • Antisense Therapeutics Limited
  • BCN Peptides, S.A.
  • Biomar Microbial Technologies
  • Charlesson LLC
  • Coherus BioSciences, Inc.
  • Crinetics Pharmaceuticals, Inc.
  • Diffusion Pharmaceuticals Inc.
  • Dimerix Bioscience Pty. Ltd.
  • Dynamis Therapeutics, Inc.
  • EyeGene, Inc.
  • Foresee Pharmaceuticals, LLC
  • GTx, Inc.
  • Icon Bioscience, Inc.
  • Islet Sciences, Inc.
  • Kodiak Sciences, Inc.
  • Kowa Company, Ltd.
  • LegoChem Biosciences, Inc.
  • Lpath, Inc.
  • M's Science Corporation
  • Mabion SA
  • MingSight Pharmaceuticals
  • OcuCure Therapeutics, Inc.
  • Oculis ehf
  • Ohr Pharmaceutical Inc.
  • PanOptica, Inc.
  • Promedior, Inc.
  • Ribomic Inc.
  • Sirnaomics, Inc.
  • Stelic Institute & Co., Inc.
  • Stemedica Cell Technologies, Inc.
  • Strongbridge Biopharma plc
  • Xbrane Biopharma AB

For more information visit http://www.researchandmarkets.com/research/d9wv59/diabetic.

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Optical, Endocrine and Metabolic Disorder Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For EST Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Optical, Endocrine and Metabolic Disorder Drugs